Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xencor Inc (XNCR) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Xencor Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1326732.
Total stock buying since 2015: $12,490,402.
Total stock sales since 2015: $119,125,940.
Total stock option exercises since 2015: $7,853,515.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 60,451 | $726,458 | 8,808 | $138,197 |
2024 | 53 | $1,013 | 230,986 | $5,042,077 | 244,546 | $3,172,546 |
2023 | 0 | $0 | 109,605 | $2,787,141 | 141,013 | $1,041,312 |
2022 | 0 | $0 | 15,673 | $451,966 | 0 | $0 |
2021 | 0 | $0 | 23,993 | $1,107,466 | 15,065 | $166,468 |
2020 | 0 | $0 | 851,903 | $25,999,506 | 10,000 | $110,500 |
2019 | 72,152 | $2,122,458 | 698,439 | $28,089,930 | 47,522 | $337,968 |
2018 | 0 | $0 | 844,069 | $33,122,882 | 353,922 | $2,010,931 |
2017 | 517,272 | $10,366,661 | 76,814 | $1,785,703 | 114,553 | $67,583 |
2016 | 25 | $270 | 592,843 | $12,614,334 | 625,310 | $537,329 |
2015 | 0 | $0 | 394,293 | $7,398,477 | 320,608 | $270,681 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-06 | 0 | $0 | 14,367 | $132,462 | 0 | $0 |
2025-05 | 0 | $0 | 4,616 | $50,914 | 0 | $0 |
2025-04 | 0 | $0 | 3,750 | $30,232 | 0 | $0 |
2025-03 | 0 | $0 | 37,718 | $512,850 | 0 | $0 |
2025-02 | 0 | $0 | 0 | $0 | 8,808 | $138,197 |
2024-12 | 0 | $0 | 14,722 | $397,932 | 14,722 | $260,211 |
2024-11 | 0 | $0 | 72,050 | $1,693,472 | 84,824 | $1,330,887 |
2024-09 | 0 | $0 | 7,509 | $155,286 | 0 | $0 |
2024-07 | 0 | $0 | 36,329 | $665,510 | 50,000 | $536,499 |
2024-05 | 0 | $0 | 4,745 | $111,872 | 0 | $0 |
2024-03 | 0 | $0 | 41,523 | $969,284 | 15,000 | $160,950 |
2024-02 | 53 | $1,013 | 54,108 | $1,048,721 | 80,000 | $883,999 |
2023-12 | 0 | $0 | 45,000 | $941,669 | 65,001 | $718,261 |
2023-06 | 0 | $0 | 33,497 | $877,286 | 76,012 | $323,051 |
2023-03 | 0 | $0 | 31,108 | $968,186 | 0 | $0 |
2022-12 | 0 | $0 | 3,737 | $100,910 | 0 | $0 |
2022-03 | 0 | $0 | 11,936 | $351,056 | 0 | $0 |
2021-12 | 0 | $0 | 3,664 | $134,179 | 0 | $0 |
2021-03 | 0 | $0 | 20,329 | $973,287 | 15,065 | $166,468 |
2020-12 | 0 | $0 | 3,777 | $165,621 | 0 | $0 |
2020-06 | 0 | $0 | 0 | $0 | 10,000 | $110,500 |
2020-04 | 0 | $0 | 644,771 | $19,001,401 | 0 | $0 |
2020-03 | 0 | $0 | 77,570 | $2,274,257 | 0 | $0 |
2020-01 | 0 | $0 | 125,785 | $4,558,227 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-06-16 | Feigal Ellen (Director) | Sale | 2,993 | 9.22 | 27,595 |
2025-06-16 | Gustafson Kurt A (Director) | Sale | 2,993 | 9.22 | 27,595 |
2025-06-16 | Montgomery Alan Bruce (Director) | Sale | 2,215 | 9.22 | 20,422 |
2025-06-16 | Ranieri Richard J (Director) | Sale | 2,993 | 9.22 | 27,595 |
2025-06-16 | Gorman Kevin Charles (Director) | Sale | 3,173 | 9.22 | 29,255 |
2025-05-02 | Valente Nancy (EVP, Chief Development Officer) | Sale | 4,616 | 11.03 | 50,914 |
2025-04-10 | Cornelissen Bart Jan (SR. VICE PRESIDENT & CFO) | Sale | 3,750 | 8.06 | 30,232 |
2025-03-10 | Valente Nancy (EVP, Chief Development Officer) | Sale | 2,565 | 13.60 | 34,876 |
2025-03-10 | Eckert Celia (SVP, GENERAL COUNSEL) | Sale | 5,740 | 13.60 | 78,046 |
2025-03-10 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Sale | 9,697 | 13.60 | 131,850 |
2025-03-10 | Dahiyat Bassil I (PRESIDENT & CEO) | Sale | 19,716 | 13.60 | 268,078 |
2025-02-03 | Dahiyat Bassil I (PRESIDENT & CEO) | Option Ex | 8,808 | 15.69 | 138,197 |
2024-12-04 | Montgomery Alan Bruce (Director) | Sale | 1,421 | 27.03 | 38,406 |
2024-12-04 | Montgomery Alan Bruce (Director) | Option Ex | 1,421 | 17.68 | 25,116 |
2024-12-02 | Montgomery Alan Bruce (Director) | Sale | 13,301 | 27.03 | 359,526 |
2024-12-02 | Montgomery Alan Bruce (Director) | Option Ex | 13,301 | 17.68 | 235,095 |
2024-11-13 | Dahiyat Bassil I (PRESIDENT & CEO) | Sale | 3,366 | 24.02 | 80,841 |
2024-11-13 | Dahiyat Bassil I (PRESIDENT & CEO) | Option Ex | 3,366 | 15.69 | 52,812 |
2024-11-12 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Option Ex | 12,774 | 15.69 | 200,424 |
2024-11-11 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Sale | 68,684 | 23.48 | 1,612,631 |
2024-11-11 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Option Ex | 68,684 | 15.69 | 1,077,651 |
2024-09-27 | Rosa-bjorkeson Dagmar (Director) | Sale | 2,503 | 20.68 | 51,762 |
2024-09-27 | Gustafson Kurt A (Director) | Sale | 2,503 | 20.68 | 51,762 |
2024-09-27 | Ranieri Richard J (Director) | Sale | 2,503 | 20.68 | 51,762 |
2024-07-10 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Option Ex | 7,785 | 10.73 | 83,533 |
2024-07-09 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Sale | 36,329 | 18.32 | 665,510 |
2024-07-09 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Option Ex | 42,215 | 10.73 | 452,966 |
2024-05-02 | Valente Nancy (EVP, Chief Development Officer) | Sale | 4,745 | 23.58 | 111,872 |
2024-03-06 | Gustafson Kurt A (Director) | Sale | 14,000 | 23.18 | 324,450 |
2024-03-06 | Gustafson Kurt A (Director) | Option Ex | 15,000 | 10.73 | 160,950 |
2024-03-05 | Eckert Celia (SVP, GENERAL COUNSEL) | Sale | 3,892 | 23.43 | 91,185 |
2024-03-05 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Sale | 6,629 | 23.43 | 155,310 |
2024-03-05 | Dahiyat Bassil I (PRESIDENT & CEO) | Sale | 12,528 | 23.43 | 293,518 |
2024-03-05 | Kuch John J (SR. VICE PRESIDENT & CFO) | Sale | 4,474 | 23.43 | 104,821 |
2024-02-14 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Option Ex | 11,943 | 11.05 | 131,970 |
2024-02-13 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Sale | 54,108 | 19.38 | 1,048,721 |
2024-02-13 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Option Ex | 68,057 | 11.05 | 752,029 |
2024-02-13 | Gorman Kevin Charles (Director) | Buy | 53 | 19.12 | 1,013 |
2023-12-29 | Dahiyat Bassil I (PRESIDENT & CEO) | Sale | 45,000 | 20.93 | 941,669 |
2023-12-29 | Dahiyat Bassil I (PRESIDENT & CEO) | Option Ex | 65,001 | 11.05 | 718,261 |
2023-06-21 | Dahiyat Bassil I (PRESIDENT & CEO) | Sale | 33,497 | 26.19 | 877,286 |
2023-06-21 | Dahiyat Bassil I (PRESIDENT & CEO) | Option Ex | 76,012 | 4.25 | 323,051 |
2023-03-09 | Yang Allen (SR. VICE PRESIDENT & CMO) | Sale | 1,094 | 29.88 | 32,687 |
2023-03-09 | Eckert Celia (VP, GENERAL COUNSEL) | Sale | 711 | 29.88 | 21,243 |
2023-03-09 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Sale | 1,230 | 29.88 | 36,751 |
2023-03-09 | Dahiyat Bassil I (PRESIDENT & CEO) | Sale | 2,602 | 29.88 | 77,745 |
2023-03-09 | Kuch John J (SR. VICE PRESIDENT & CFO) | Sale | 711 | 29.88 | 21,243 |
2023-03-06 | Yang Allen (SR. VICE PRESIDENT & CMO) | Sale | 4,069 | 31.42 | 127,831 |
2023-03-06 | Eckert Celia (VP, GENERAL COUNSEL) | Sale | 2,462 | 31.42 | 77,346 |
2023-03-06 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Sale | 4,195 | 31.42 | 131,790 |
2023-03-06 | Dahiyat Bassil I (PRESIDENT & CEO) | Sale | 5,831 | 31.42 | 183,186 |
2023-03-06 | Kuch John J (SR. VICE PRESIDENT & CFO) | Sale | 2,774 | 31.42 | 87,147 |
2023-03-03 | Eckert Celia (VP, GENERAL COUNSEL) | Sale | 427 | 31.54 | 13,466 |
2023-03-03 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Sale | 1,232 | 31.54 | 38,854 |
2023-03-03 | Dahiyat Bassil I (PRESIDENT & CEO) | Sale | 2,851 | 31.54 | 89,914 |
2023-03-03 | Kuch John J (SR. VICE PRESIDENT & CFO) | Sale | 919 | 31.54 | 28,983 |
2022-12-19 | Yang Allen (SR. VICE PRESIDENT & CMO) | Sale | 3,737 | 27.00 | 100,910 |
2022-03-09 | Yang Allen (SR. VICE PRESIDENT & CMO) | Sale | 1,200 | 28.94 | 34,723 |
2022-03-09 | Eckert Celia (VP, GENERAL COUNSEL) | Sale | 789 | 28.91 | 22,809 |
2022-03-09 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Sale | 1,172 | 29.13 | 34,140 |
2022-03-09 | Dahiyat Bassil I (PRESIDENT & CEO) | Sale | 2,494 | 29.00 | 72,326 |
2022-03-09 | Kuch John J (SR. VICE PRESIDENT & CFO) | Sale | 690 | 28.93 | 19,965 |
2022-03-03 | Eckert Celia (VP, GENERAL COUNSEL) | Sale | 451 | 29.91 | 13,487 |
2022-03-03 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Sale | 1,240 | 29.86 | 37,032 |
2022-03-03 | Dahiyat Bassil I (PRESIDENT & CEO) | Sale | 2,929 | 29.90 | 87,580 |
2022-03-03 | Kuch John J (SR. VICE PRESIDENT & CFO) | Sale | 971 | 29.86 | 28,994 |
2021-12-17 | Yang Allen (SR. VICE PRESIDENT & CMO) | Sale | 3,664 | 36.62 | 134,179 |
2021-03-03 | Eckert Celia (VP, GENERAL COUNSEL) | Sale | 444 | 44.94 | 19,954 |
2021-03-03 | Desjarlais John R (SR. VICE PRESIDENT & CSO) | Sale | 1,165 | 45.02 | 52,454 |
2021-03-03 | Dahiyat Bassil I (PRESIDENT & CEO) | Sale | 2,850 | 44.88 | 127,908 |
2021-03-03 | Kuch John J (SR. VICE PRESIDENT & CFO) | Sale | 805 | 45.09 | 36,293 |
2021-03-01 | Kuch John J (SR. VICE PRESIDENT & CFO) | Sale | 15,065 | 48.90 | 736,678 |
2021-03-01 | Kuch John J (SR. VICE PRESIDENT & CFO) | Option Ex | 15,065 | 11.05 | 166,468 |
2020-12-17 | Yang Allen (SR. VICE PRESIDENT & CMO) | Sale | 3,777 | 43.85 | 165,621 |
2020-06-12 | Kuch John J (Sr. Vice President & CFO) | Option Ex | 10,000 | 11.05 | 110,500 |
2020-04-06 | Stafford John S Iii | Sale | 644,771 | 29.47 | 19,001,401 |
2020-03-20 | Stafford John S Iii | Sale | 50,770 | 29.89 | 1,517,667 |
2020-03-19 | Stafford John S Iii | Sale | 26,800 | 28.23 | 756,590 |
2020-01-08 | Stafford John S Iii | Sale | 60,876 | 36.68 | 2,232,931 |
2020-01-07 | Stafford John S Iii | Sale | 6,047 | 35.95 | 217,389 |
2020-01-06 | Stafford John S Iii | Sale | 58,862 | 35.81 | 2,107,907 |
2019-12-26 | Stafford John S Iii | Sale | 4,119 | 40.04 | 164,924 |
2019-12-24 | Stafford John S Iii | Sale | 43,720 | 39.71 | 1,736,121 |
2019-12-23 | Stafford John S Iii | Sale | 91,677 | 39.51 | 3,622,341 |
2019-12-20 | Stafford John S Iii | Sale | 73,423 | 39.39 | 2,892,131 |
2019-12-11 | Stafford John S Iii | Sale | 37,951 | 38.68 | 1,467,944 |
2019-12-10 | Stafford John S Iii | Sale | 252,225 | 40.13 | 10,121,789 |
2019-12-09 | Stafford John S Iii | Sale | 120,324 | 41.64 | 5,009,810 |
2019-09-06 | Desjarlais John R (Sr. V.P., Research & CSO) | Option Ex | 27,522 | 4.25 | 116,968 |
2019-08-21 | Kuch John J (Sr. Vice President & CFO) | Sale | 40,000 | 41.27 | 1,650,720 |
2019-08-21 | Kuch John J (Sr. Vice President & CFO) | Option Ex | 20,000 | 11.05 | 221,000 |
2019-08-19 | Desjarlais John R (Sr. V.P., Research & CSO) | Sale | 35,000 | 40.69 | 1,424,150 |
2019-06-06 | Ronin Capital, Llc | Buy | 12,641 | 29.87 | 377,586 |
2019-05-02 | Ronin Capital, Llc | Buy | 14,611 | 29.87 | 436,401 |
2019-03-25 | Ronin Capital, Llc | Buy | 3,500 | 29.77 | 104,195 |
2019-03-22 | Ronin Capital, Llc | Buy | 2,000 | 29.96 | 59,920 |
2019-03-18 | Ronin Capital, Llc | Buy | 1,100 | 29.90 | 32,890 |
2019-03-15 | Ronin Capital, Llc | Buy | 38,300 | 29.02 | 1,111,466 |
2018-09-17 | Foster Paul A (Chief Medical Officer) | Sale | 40,000 | 46.03 | 1,841,200 |
2018-09-17 | Foster Paul A (Chief Medical Officer) | Option Ex | 40,000 | 11.05 | 442,000 |
2018-09-14 | Ronin Capital, Llc | Sale | 1,000 | 48.05 | 48,054 |
2018-08-17 | Foster Paul A (Chief Medical Officer) | Sale | 3,659 | 40.10 | 146,725 |
2018-08-17 | Foster Paul A (Chief Medical Officer) | Option Ex | 3,659 | 11.05 | 40,431 |
2018-08-16 | Foster Paul A (Chief Medical Officer) | Sale | 20,739 | 41.10 | 852,372 |
2018-08-16 | Foster Paul A (Chief Medical Officer) | Option Ex | 20,739 | 11.05 | 229,165 |
2018-08-15 | Foster Paul A (Chief Medical Officer) | Sale | 106 | 41.10 | 4,356 |
2018-08-15 | Foster Paul A (Chief Medical Officer) | Option Ex | 106 | 11.05 | 1,171 |
2018-08-14 | Foster Paul A (Chief Medical Officer) | Sale | 15,496 | 41.11 | 636,978 |
2018-08-14 | Foster Paul A (Chief Medical Officer) | Option Ex | 15,496 | 11.05 | 171,230 |
2018-08-13 | Baracchini Edgardo Jr (Chief Business Officer) | Sale | 12,734 | 40.35 | 513,880 |
2018-08-13 | Baracchini Edgardo Jr (Chief Business Officer) | Option Ex | 12,734 | 11.05 | 140,710 |
2018-08-10 | Desjarlais John R (Sr. V.P., Research & CSO) | Sale | 14,867 | 40.03 | 595,096 |
2018-08-10 | Baracchini Edgardo Jr (Chief Business Officer) | Sale | 28,983 | 40.02 | 1,160,044 |
2018-08-09 | Desjarlais John R (Sr. V.P., Research & CSO) | Sale | 20,133 | 40.61 | 817,621 |
2018-08-09 | Desjarlais John R (Sr. V.P., Research & CSO) | Option Ex | 35,000 | 4.25 | 148,750 |
2018-08-09 | Baracchini Edgardo Jr (Chief Business Officer) | Sale | 8,283 | 40.35 | 334,202 |
2018-08-09 | Baracchini Edgardo Jr (Chief Business Officer) | Option Ex | 37,266 | 11.05 | 411,789 |
2018-07-17 | Ronin Capital, Llc | Sale | 36,500 | 41.24 | 1,505,260 |
2018-07-16 | Ronin Capital, Llc | Sale | 26,888 | 40.67 | 1,093,534 |
2018-07-13 | Ronin Capital, Llc | Sale | 48,312 | 41.97 | 2,027,702 |
2018-07-12 | Ronin Capital, Llc | Sale | 58,000 | 39.55 | 2,293,900 |
2018-07-11 | Ronin Capital, Llc | Sale | 30,007 | 39.63 | 1,189,177 |
2018-07-10 | Ronin Capital, Llc | Sale | 50,293 | 39.89 | 2,006,187 |
2018-06-20 | Ronin Capital, Llc | Sale | 92,779 | 40.05 | 3,715,798 |
2018-06-19 | Ronin Capital, Llc | Sale | 103,454 | 39.77 | 4,114,365 |
2018-06-18 | Ronin Capital, Llc | Sale | 53,767 | 39.88 | 2,144,227 |
2018-06-15 | Dahiyat Bassil I (President and CEO) | Sale | 50,000 | 40.51 | 2,025,700 |
2018-06-15 | Dahiyat Bassil I (President and CEO) | Option Ex | 50,000 | 4.25 | 212,500 |
2018-06-13 | Kuch John J (Sr. Vice President & CFO) | Sale | 25,000 | 41.64 | 1,040,950 |
2018-06-13 | Kuch John J (Sr. Vice President & CFO) | Option Ex | 35,853 | 4.25 | 152,375 |
2018-03-15 | Baracchini Edgardo Jr (Chief Business Officer) | Sale | 40,000 | 30.89 | 1,235,760 |
2018-03-15 | Baracchini Edgardo Jr (Chief Business Officer) | Option Ex | 40,000 | .59 | 23,600 |
2018-03-05 | Baracchini Edgardo Jr (Chief Business Officer) | Sale | 10,000 | 29.58 | 295,840 |
2018-03-05 | Baracchini Edgardo Jr (Chief Business Officer) | Option Ex | 10,000 | .59 | 5,900 |
2018-03-02 | Baracchini Edgardo Jr (Chief Business Officer) | Sale | 10,000 | 29.60 | 295,970 |
2018-03-02 | Baracchini Edgardo Jr (Chief Business Officer) | Option Ex | 10,000 | .59 | 5,900 |
2018-02-27 | Baracchini Edgardo Jr (Chief Business Officer) | Sale | 20,000 | 29.64 | 592,840 |
2018-02-27 | Baracchini Edgardo Jr (Chief Business Officer) | Option Ex | 20,000 | .59 | 11,800 |
2018-02-22 | Foster Paul A (Chief Medical Officer) | Sale | 10,000 | 26.03 | 260,300 |
2018-02-22 | Foster Paul A (Chief Medical Officer) | Option Ex | 10,000 | .59 | 5,900 |
2018-02-22 | Baracchini Edgardo Jr (Chief Business Officer) | Sale | 8,069 | 26.00 | 209,794 |
2018-02-22 | Baracchini Edgardo Jr (Chief Business Officer) | Option Ex | 8,069 | .59 | 4,760 |
2018-02-16 | Foster Paul A (Chief Medical Officer) | Sale | 5,000 | 25.01 | 125,050 |
2018-02-16 | Foster Paul A (Chief Medical Officer) | Option Ex | 5,000 | .59 | 2,950 |
2017-12-14 | Ronin Capital, Llc | Buy | 3,000 | 20.84 | 62,505 |
2017-12-12 | Ronin Capital, Llc | Buy | 6,215 | 20.72 | 128,774 |
2017-11-28 | Ronin Capital, Llc | Buy | 10,025 | 19.86 | 199,096 |
2017-11-24 | Ronin Capital, Llc | Buy | 5,349 | 19.85 | 106,177 |
2017-11-10 | Ronin Capital, Llc | Buy | 324 | 19.90 | 6,447 |
2017-11-09 | Ronin Capital, Llc | Buy | 38,099 | 19.91 | 758,551 |
Insider trading activities including stock purchases, stock sales, and option exercises of XNCR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Xencor Inc (symbol XNCR, CIK number 1326732) see the Securities and Exchange Commission (SEC) website.